216 related articles for article (PubMed ID: 35789184)
1. Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction.
Moreno-Rabié C; Lapauw L; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; van den Wyngaert T; Jacobs R
Sci Rep; 2022 Jul; 12(1):11280. PubMed ID: 35789184
[TBL] [Abstract][Full Text] [Related]
2. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
Moreno-Rabié C; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; Gielen E; Van den Wyngaert T; Jacobs R
Oral Dis; 2024 Apr; 30(3):1632-1642. PubMed ID: 36620873
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
[TBL] [Abstract][Full Text] [Related]
4. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
[TBL] [Abstract][Full Text] [Related]
5. Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.
Hasegawa T; Hayashida S; Kondo E; Takeda Y; Miyamoto H; Kawaoka Y; Ueda N; Iwata E; Nakahara H; Kobayashi M; Soutome S; Yamada SI; Tojyo I; Kojima Y; Umeda M; Fujita S; Kurita H; Shibuya Y; Kirita T; Komori T;
Osteoporos Int; 2019 Jan; 30(1):231-239. PubMed ID: 30406309
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
[TBL] [Abstract][Full Text] [Related]
7. Why do some extraction sites develop medication-related osteonecrosis of the jaw and others do not? A within-patient study assessing radiographic predictors.
Gaêta-Araujo H; Ferreira Leite A; de Faria Vasconcelos K; Coropciuc R; Politis C; Jacobs R; Oliveira-Santos C
Int J Oral Implantol (Berl); 2021 Mar; 14(1):87-98. PubMed ID: 34006074
[TBL] [Abstract][Full Text] [Related]
8. Medication related osteonecrosis of the jaw in osteoporotic
Walton K; Grogan TR; Eshaghzadeh E; Hadaya D; Elashoff DA; Aghaloo TL; Tetradis S
Dentomaxillofac Radiol; 2019 Jan; 48(1):20180128. PubMed ID: 29952657
[TBL] [Abstract][Full Text] [Related]
9. Association between periodontal disease, tooth extraction, and medication-related osteonecrosis of the jaw in women receiving bisphosphonates: A national cohort-based study.
Kwoen MJ; Park JH; Kim KS; Lee JR; Kim JW; Lee H; Lee HJ
J Periodontol; 2023 Jan; 94(1):98-107. PubMed ID: 35856336
[TBL] [Abstract][Full Text] [Related]
10. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
Moreno-Rabié C; Fontenele RC; Oliveira-Santos N; Nogueira-Reis F; Van den Wyngaert T; Jacobs R
Osteoporos Int; 2024 May; ():. PubMed ID: 38767743
[TBL] [Abstract][Full Text] [Related]
11. Pre-existing medication-related osteonecrosis of the jaw before dental extraction.
Al-Sarraj M; Burns M; Patel V
Br Dent J; 2023 Nov; 235(10):783-788. PubMed ID: 38001199
[TBL] [Abstract][Full Text] [Related]
12. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
Ueda N; Nakashima C; Aoki K; Shimotsuji H; Nakaue K; Yoshioka H; Kurokawa S; Imai Y; Kirita T
Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886
[TBL] [Abstract][Full Text] [Related]
13. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
[TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
15. Radiographic perception of anatomical structures and bony changes in oncologic patients under antiresorptive therapy.
Gaêta-Araujo H; Pinheiro MCR; Leite AF; Vasconcelos KF; Jacobs R; Oliveira-Santos C
Support Care Cancer; 2023 Feb; 31(2):149. PubMed ID: 36737557
[TBL] [Abstract][Full Text] [Related]
16. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.
Shin JW; Kim JE; Huh KH; Yi WJ; Heo MS; Lee SS; Choi SC
Sci Rep; 2024 Apr; 14(1):8744. PubMed ID: 38627515
[TBL] [Abstract][Full Text] [Related]
17. Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study.
Hasegawa T; Ueda N; Yamada SI; Kato S; Iwata E; Hayashida S; Kojima Y; Shinohara M; Tojo I; Nakahara H; Yamaguchi T; Kirita T; Kurita H; Shibuya Y; Soutome S; Akashi M;
Osteoporos Int; 2021 Nov; 32(11):2323-2333. PubMed ID: 33997909
[TBL] [Abstract][Full Text] [Related]
18. Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.
Hadad H; Matheus HR; Pai SI; Souza FA; Guastaldi FPS
Arch Oral Biol; 2024 Mar; 159():105875. PubMed ID: 38160519
[TBL] [Abstract][Full Text] [Related]
19. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
20. A Retrospective Data Analysis for the Risk Evaluation of the Development of Drug-Associated Jaw Necrosis through Dentoalveolar Interventions.
Buchbender M; Bauerschmitz C; Pirkl S; Kesting MR; Schmitt CM
Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
